Fig. 4. Pancreatic defects in PdxCreearly
ß-catactive correlate with changes in FGF and hedgehog
signaling, and loss of Pdx1+ progenitor cells. (A-C)
Whole-mount in situ hybridization. Fgf10 expression is downregulated
in the dorsal pancreatic (dp) and ventral pancreatic (vp) mesenchyme of the
PdxCreearly ß-catactive mutants
(C) at E10.5. Fgf10 expression within the pancreatic mesenchyme of
PdxCrelate ß-catactive mutants
(B) is equivalent to control (A). s, stomach. (D-F) Immunohistochemical
staining. Pancreatic sections at E12.5 stained for the hedgehog (Hh) receptor
Ptch1 reveal increased levels of Ptch1 within the pancreatic epithelium
(circled in blue) of the PdxCreearly
ß-catactive mutants (F) when compared with control
pancreas (D). Ptch1 staining in PdxCrelate
ß-catactive (E) pancreatic sections is equivalent to
control (D). (G-I) Pancreatic sections at E12.5 stained for Hh. The
PdxCreearly ß-catactive
pancreatic epithelium (circled in blue, I) also exhibits increased levels of
Hh when compared with control (G) and PdxCrelate
ß-catactive pancreas tissue (H). (J-L)
Staining of E12.5 pancreata with E-cadherin (green) to mark the pancreatic
epithelium and Pdx1 (red) reveals a dramatic loss of Pdx1+ progenitor cells in
the PdxCreearly ß-catactive
mutants (L). By contrast, the PdxCrelate
ß-catactive (K) display Pdx1+ cell numbers
that are equivalent to control (J). Scale bars: 50 µm in J-L.